Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David J. Lauffer is active.

Publication


Featured researches published by David J. Lauffer.


Bioorganic & Medicinal Chemistry Letters | 1994

The synthesis and evaluation of peptidyl aspartyl aldehydes as inhibitors of ice.

Michael Mullican; David J. Lauffer; Roger John Gillespie; Saroop S. Matharu; David Kay; Geoffrey M. Porritt; Phillip L. Evans; Julian Golec; Mark A. Murcko; Yu-Ping Luong; Scott A. Raybuck; David J. Livingston

Abstract The tetrapeptide aldehyde Ac-Tyr-Val-Ala-AspH ( 1 , L-709,049) has been reported to be a potent reversible inhibitor of Interleukin-1β Converting Enzyme (ICE). We have prepared a series of analogs of 1 , in order to explore the active sige of ICE. The effects of truncation, methylation of the amide nitrogens and modification of the aldehyde group of 1 are presented.


Bioorganic & Medicinal Chemistry Letters | 2010

3-Aryl-4-(arylhydrazono)-1H-pyrazol-5-ones: Highly ligand efficient and potent inhibitors of GSK3beta.

Michael J. Arnost; Al Pierce; Ernst ter Haar; David J. Lauffer; Jaren Madden; Kirk Tanner; Jeremy Green

A series of 3-aryl-4-(arylhydrazono)-1H-pyrazol-5-one inhibitors of GSK3beta was developed from a low molecular weight, highly ligand efficient screening hit 1. Hit-to-lead optimization led to a number of highly potent inhibitors, while maintaining the high ligand efficiency of the screening hit.


Bioorganic & Medicinal Chemistry Letters | 2002

A practical synthesis of (S) 3-tert-Butoxycarbonylamino-2-oxo-2,3,4,5-tetrahydro-1,5-benzodiazepine-1-acetic acid methyl ester as a conformationally restricted dipeptido-Mimetic for caspase-1 (ICE) inhibitors

David J. Lauffer; Michael Mullican

A simple and versatile method for the synthesis of (S) 3-tert-butoxycarbonylamino-2-oxo-2,3,4,5-tetrahydro-1,5-benzodiazepine-1-acetic acid methyl ester (4), a dipeptide mimetic, has been developed. The regioselective functionalization of the N1 and N5 ring nitrogens and the C3 amino group is demonstrated in the synthesis of an interleukin-1beta converting enzyme inhibitor 13.


Archive | 1995

Inhibitors of interleukin-1β converting enzyme

Guy W. Bemis; Julian Golec; David J. Lauffer; Michael Mullican; Mark A. Murcko; David J. Livingston


Archive | 2005

Azaindoles useful as inhibitors of JAK and other protein kinases

Francesco Salituro; Luc J. Farmer; Randy S. Bethiel; Edmund Harrington; Jeremy Green; John J. Court; Jon H. Come; David J. Lauffer; Alex Aronov; Hayley Binch; Dean Boyall; Jean-Damien Charrier; Simon Everitt; Damien Fraysse; Michael Mortimore; Francoise Pierard; Daniel Robinson; Jian Wang; Joanne Pinder; Tiansheng Wang; Albert Pierce


Archive | 2006

Inhibitors of c-met and uses thereof

David J. Lauffer; Alexander Aronov; Pan Li; David D. Deininger; Kira Mcginty; Dean Stamos; Jon H. Come; Michelle Stewart


Archive | 1999

Inhibitors of caspases

Marion W. Wannamaker; Guy W. Bemis; Paul S. Charifson; David J. Lauffer; Michael Mullican; Mark A. Murcko; Keith P. Wilson; James W. Janetka; Robert J. Davies; Anne-Laure Grillot; Zhan Shi; Cornelia J. Forster


Archive | 2007

Deazapurines useful as inhibitors of janus kinases

Francesco Salituro; Luc J. Farmer; Tiansheng Wang; Jian Wang; Randy S. Bethiel; Marion W. Wannamaker; Gabriel Martinez-Botella; John P. Duffy; Alexander Aronov; David J. Lauffer; Albert Pierce


Archive | 2003

INDAZOLINONE COMPOSITIONS USEFUL AS KINASE INHIBITORS

Alex Aronov; David J. Lauffer; Huan Qui Li; Ronald Tomlinson; Pan Li


Archive | 2007

c-MET protein kinase inhibitors for the treatment of proliferative disorders

David J. Lauffer; Robert J. Davies; Dean Stamos; Alexander Aronov; David D. Deininger; Ronald Grey; Jinwang Xu; Pan Li; Brian Ledford; Luc J. Farmer; Randy S. Bethiel; Dylan Jacobs; Kira Mcginty

Collaboration


Dive into the David J. Lauffer's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Pan Li

Vertex Pharmaceuticals

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge